0
Startups & Venture·October 23, 2026·1 min read

Jio’s Record IPO Draws Strong Demand, Defying India Market Rout

Share

Jio’s $3.1B IPO drawing strong institutional demand despite a broader India selloff underlines how investors are still willing to pay for scaled digital infrastructure plays. If you’re building in India’s consumer or infra stack, this is a green light that public markets will reward real network effects and cashflow, even through volatility.

Startups & Venture

Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from a $1.6B valuation in May 2025

Pathos AI nearly doubling valuation to $3B in ~18 months on a $237M Series E is a clear vote that AI-native drug discovery—especially in oncology—is moving from story to pipeline. If you’re a traditional biotech, expect investors and partners to benchmark your discovery engine against AI-first peers on cycle time and hit quality, not just clinical endpoints.